Literature DB >> 2148984

Omeprazole and ranitidine in duodenal ulcer healing. Analysis of comparative clinical trials.

C J Mulder1, D L Schipper.   

Abstract

Ten double-blind randomized studies with omeprazole versus ranitidine in duodenal ulcer healing have been published. The total number of patients in the trials amounted to 2225. To detect treatment differences, a meta-analysis was performed. After 2 and 4 weeks of treatment results have been evaluated. After 2 weeks of treatment omeprazole produced higher healing rates than ranitidine in nine studies. However, at 4 weeks numerical differences in favour of omeprazole were found in nine studies. Relief of ulcer symptoms occurred more rapidly with omeprazole than ranitidine. No major clinical or biochemical side effects were recorded. However, no data are available about maintenance therapy in double-blind randomized studies comparing both drugs or about rebleeding rates in bleeding duodenal ulcer treatment.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2148984     DOI: 10.3109/00365529009093152

Source DB:  PubMed          Journal:  Scand J Gastroenterol Suppl        ISSN: 0085-5928


  6 in total

Review 1.  Omeprazole: a pharmacoeconomic evaluation of its use in duodenal ulcer and reflux oesophagitis.

Authors:  L B Barradell; D McTavish
Journal:  Pharmacoeconomics       Date:  1993-06       Impact factor: 4.981

Review 2.  Ranitidine: a pharmacoeconomic evaluation of its use in acid-related disorders.

Authors:  J E Frampton; D McTavish
Journal:  Pharmacoeconomics       Date:  1994-07       Impact factor: 4.981

Review 3.  Omeprazole. An updated review of its pharmacology and therapeutic use in acid-related disorders.

Authors:  D McTavish; M M Buckley; R C Heel
Journal:  Drugs       Date:  1991-07       Impact factor: 9.546

Review 4.  Histamine H2-receptor antagonists in peptic ulcer disease. Efficacy in healing peptic ulcers.

Authors:  M Deakin; J G Williams
Journal:  Drugs       Date:  1992-11       Impact factor: 9.546

5.  A double-blind study of pantoprazole and ranitidine in treatment of acute duodenal ulcer. A multicenter trial. European Pantoprazole Study Group.

Authors:  M Cremer; R Lambert; C B Lamers; G Delle Fave; C Maier
Journal:  Dig Dis Sci       Date:  1995-06       Impact factor: 3.199

6.  External validation of a measurement tool to assess systematic reviews (AMSTAR).

Authors:  Beverley J Shea; Lex M Bouter; Joan Peterson; Maarten Boers; Neil Andersson; Zulma Ortiz; Tim Ramsay; Annie Bai; Vijay K Shukla; Jeremy M Grimshaw
Journal:  PLoS One       Date:  2007-12-26       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.